Outpatient experience with saralasin.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000804:Angiotensin II / Q000031:analogs & derivatives* / Q000378:metabolism; D001794:Blood Pressure / Q000187:drug effects; D005188:False Negative Reactions; D005260:Female; D005665:Furosemide / Q000494:pharmacology; D006801:Humans; D006977:Hypertension, Renal / Q000175:diagnosis* / Q000378:metabolism; D008297:Male; D008722:Methods; D008875:Middle Aged; D011187:Posture; D011433:Propranolol / Q000627:therapeutic use; D012078:Renal Artery Obstruction / Q000150:complications / Q000378:metabolism; D012083:Renin / Q000097:blood; D012504:Saralasin / Q000378:metabolism / Q000494:pharmacology; D012965:Sodium Chloride / Q000378:metabolism / Q000494:pharmacology
D000804:Angiotensin II; D012965:Sodium Chloride; D005665:Furosemide; D011433:Propranolol; D012083:Renin; D012504:Saralasin